tm logo
AKAMIS BIO
Live/Registered
REGISTERED

on 05 Nov 2024

Last Applicant/ Owned by

Abingdon Science Park, Barton Lane

Abingdon, Oxfordshire

OX143YS

Serial Number

97823138 filed on 04th Mar 2023

Registration Number

7554922 registered on 05th Nov 2024

in the Principal Register

Correspondent Address

Jennifer Insley-Pruitt

Jennifer Insley-Pruitt Dechert LLP

NEW YORK, NY 10036

UNITED STATES

Filing Basis

1. intent to use

Disclaimer

NO DATA

AKAMIS BIO

Pharmaceutical research and development services; pharmaceutical drug development services; research and development ofnew pharmaceutical products for others; biomedical research services; medicine development service; pharmaceutical research;biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; scientific and medicalresearch in the nature o Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Pharmaceutical research and development services; pharmaceutical drug development services; research and development ofnew pharmaceutical products for others; biomedical research services; medicine development service; pharmaceutical research;biochemical research and analysis; scientific research in the nature of conducting clinical trials for others; scientific and medicalresearch in the nature of genome organization and functional analysis; genetic testing for scientific research purposes; researchand development services in the field of immunology, biotechnology, oncology, medicine, gene therapy, immunotherapy andtherapeutics; technological consulting services, namely, product development consultation relating to the manufacture ofpharmaceuticals; technological consulting services, namely, product development consultation relating to the design ofmanufacturing methods for pharmaceuticals; advisory, information and consultancy services relating to the aforementionedservices


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [035]
Advertising, Business & Retail Services


Marketing services in the field of pharmaceutical products; product marketing services in the field of pharmaceutical products;market research in the field of pharmaceutical products; market forecasting in the field of pharmaceutical products; marketevaluation services, namely, market analysis and research services in the field of pharmaceutical products; online retail andwholesale store services for pharmaceutical products; online retail and wholesale store services for pharmaceutical preparations;advisory, information and consultancy services relating to the aforementioned services


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Pharmaceutical preparations and substances for the treatment of oncological diseases and disorders; pharmaceutical compositions for the treatment of oncological diseases and disorders; biotechnological preparations for the medical treatment of solid tumors; biotechnological preparations for the treatment of oncological diseases and disorders


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97823138

Mark Type

No Service Mark

Attorney Docket Number

No 201899-062

44D Filed

Yes

44D Current

No

44E filed

No

44E Current

Yes

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

26.01.02 -

Plain single line circles

26.15.21 -

Polygons that are completely or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

Legal History


Show more

Status DateAction Taken
05th Nov 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
05th Nov 2024REGISTERED-PRINCIPAL REGISTER
20th Aug 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
20th Aug 2024PUBLISHED FOR OPPOSITION
31st Jul 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
17th Jul 2024APPROVED FOR PUB - PRINCIPAL REGISTER
17th Jul 2024NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
17th Jul 2024EXAMINER'S AMENDMENT ENTERED
17th Jul 2024EXAMINERS AMENDMENT E-MAILED
17th Jul 2024EXAMINERS AMENDMENT -WRITTEN